Biophytis (BPTS) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free BPTS Stock Alerts Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartFinancialsHeadlinesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 23, 2024 | marketbeat.comTrading was temporarily halted for "BPTS" at 07:04 PM with a stated reason of "News pending."April 9, 2024 | theglobeandmail.comBiotech Catches Major Premarket Bid Following Financial ResultsApril 9, 2024 | finance.yahoo.comWhy Is Penny Stock Biophytis Trading Higher On Tuesday?April 9, 2024 | investorplace.comWhy Is Biophytis (BPTS) Stock Up 43% Today?April 8, 2024 | finanznachrichten.deBiophytis announces its 2023 financial results -2-April 4, 2024 | finance.yahoo.comResults of the Combined General Meeting on April 2, 2024March 22, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Slightly Higher in Friday TradingMarch 19, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Flat in Tuesday TradingMarch 12, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday TradingDecember 20, 2023 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Edge Higher WednesdayOctober 30, 2023 | finance.yahoo.comBiophytis and Innovation Solutions Pharma Sign a Partnership Agreement to Accelerate Market Access for Sarconeos (BIO101) in BrazilOctober 27, 2023 | marketwatch.comBiophytis ADS Fall 8.5% in After Receiving Nasdaq NoticeOctober 27, 2023 | finance.yahoo.comBiophytis Receives Notice of Delisting From NASDAQ and Announces It Will Request a Hearing Before the NASDAQ Hearings PanelSeptember 29, 2023 | proactiveinvestors.comBiophytis shares surge 41% following Covid partnership with France's SkyepharmaSeptember 26, 2023 | finance.yahoo.comBiophytis (BPTS) Soars 73% on Partnership With SkyepharmaSeptember 25, 2023 | benzinga.comWhy Biophytis (BPTS) Shares Are Sky-RocketingSeptember 25, 2023 | markets.businessinsider.comBiophytis Shares Surge 79% Following Covid-19 Partnership With SkyepharmaSeptember 25, 2023 | marketbeat.comTrading was temporarily halted for "BPTS" at 11:09 AM with a stated reason of "LULD pause."September 25, 2023 | marketwatch.comBiophytis Shares Rise 41% After Partnership Deal With SkyepharmaSeptember 25, 2023 | finance.yahoo.comBiophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101)September 25, 2023 | msn.comWhy Is Biophytis (BPTS) Stock Up 49% Today?September 25, 2023 | finance.yahoo.comBiophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101)September 20, 2023 | finanznachrichten.deBiophytis Provides an Update on its Early Access Programs for Sarconeos in the Treatment of Severe Forms of COVID-19September 19, 2023 | finance.yahoo.comBiophytis Provides an Update on its Early Access Programs for Sarconeos (BIO101) in the Treatment of Severe Forms of COVID-19September 14, 2023 | finance.yahoo.comBiophytis Strengthens its Management Team with the Appointment of its Chief Business OfficerSeptember 11, 2023 | finanznachrichten.deBiophytis Obtains FDA Authorization to Initiate the SARA-31 Phase 3 Study in SarcopeniaSeptember 11, 2023 | finance.yahoo.comBiophytis Obtains FDA Authorization to Initiate the SARA-31 Phase 3 Study in SarcopeniaSeptember 4, 2023 | finance.yahoo.comBiophytis to Participate at the H.C. Wainwright 25th Global Investment Conference in New YorkAugust 16, 2023 | finance.yahoo.comBiophytis Announces Next Regulatory Steps in Europe and the United States for its COVA ProjectAugust 8, 2023 | msn.comWhy Is Biophytis (BPTS) Stock Up 18% Today?August 8, 2023 | finance.yahoo.comBiophytis Receives a Positive Opinion for its SARA-31 Phase 3 Study in Sarcopenia in EuropeJuly 20, 2023 | marketwatch.comBiophytis Shares Drop 11% After Request for Meeting With FDA on Covid-19 TreatmentJuly 20, 2023 | finance.yahoo.comBiophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19July 20, 2023 | finance.yahoo.comBiophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19July 19, 2023 | marketwatch.comBiophytis Shares Drop 12% on Direct Offering PricingJuly 19, 2023 | marketbeat.comTrading was temporarily halted for "BPTS" at 10:07 AM with a stated reason of "LULD pause."July 19, 2023 | finanznachrichten.deBiophytis Announces USD3.8 Million Registered Direct OfferingJuly 19, 2023 | finance.yahoo.comBiophytis Announces $3.8 Million Registered Direct OfferingJuly 18, 2023 | seekingalpha.comiCAD, Biophytis top healthcare gainers; Lixte, Masimo lead losers packJuly 18, 2023 | benzinga.comWhy Are Biophytis Shares Skyrocketing Today?July 18, 2023 | msn.comBiophytis and SEQENS will together produce Sarconeos active compoundJune 19, 2023 | finanznachrichten.deBiophytis Reports Clinical Results for Sarconeos in Sarcopenia Treatment at the 16th SCWD International CongressJune 19, 2023 | finance.yahoo.comBiophytis Reports Clinical Results for Sarconeos (BIO101) in Sarcopenia Treatment at the 16th SCWD International CongressJune 16, 2023 | finance.yahoo.comBiophytis: Results of the Annual General Meeting on June 16, 2023 All Resolutions Presented by the Company Have Been AdoptedJune 5, 2023 | finance.yahoo.comBiophytis to Participate at the BIO International Convention in Boston from the 5th to the 8th of JuneMay 26, 2023 | finance.yahoo.comBiophytis has Filed with the French National Authority for Health (HAS) an Application for Early Access Authorisation (EAA) for Sarconeos (BIO101) in the Treatment of Severe Forms of COVID-19May 25, 2023 | msn.comBiophytis ticks higher after presenting COVID drug data at conferenceMay 25, 2023 | finance.yahoo.comBiophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International ConferenceMay 11, 2023 | marketwatch.comSuccessful Capital Increase for Biophytis with EUR2.3 million RaisedMay 11, 2023 | marketbeat.comTrading was temporarily halted for "BPTS" at 09:05 AM with a stated reason of "LULD pause." Get Biophytis News Delivered to You Automatically Sign up to receive the latest news and ratings for BPTS and its competitors with MarketBeat's FREE daily newsletter. Email Address The only financial event in 2024 that matters (Ad)Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral. Stream the documentary for free by clicking here BPTS Media Mentions By Week BPTS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPTS News Sentiment▼0.000.76▲Average Medical News Sentiment BPTS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPTS Articles This Week▼00▲BPTS Articles Average Week Get Biophytis News Delivered to You Automatically Sign up to receive the latest news and ratings for BPTS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ARDS News Today ARAV News Today ONCO News Today QNRX News Today LGVN News Today BDRX News Today AGRX News Today SNOA News Today APVO News Today MBIO News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BPTS) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biophytis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
